Advertisement

Related Videos

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Welcome and Introduction to Vi3C

Opportunities to Optimize Cancer Policies Panel Discussion

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Feb
05
Today In Oncology
Metastasis-Directed Therapy for Oligometastatic Prostate Cancer
New European Project Cluster EARLYSCAN Launched to Advance Early Detection of Heritable Cancers
First-Line mFOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type mCRC
WHO Analysis Finds Many Global Cancer Cases Attributable to Modifiable Risk Factors
Addition of Palbociclib to Standard Therapy in Hormone Receptor–Positive, HER2-Positive Metastatic Breast Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo